PSY 349 Midterm 1

0.0(0)
studied byStudied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/57

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 9:26 PM on 3/4/25
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

58 Terms

1
New cards
OARS motivational interviewing technique
Open-ended questions, Affirmations, Reflective listening, and Summaries.
2
New cards
Cognitive-behavioral therapy (CBT) for substance use disorders (SUDs)
Helps individuals develop coping skills and cognitive techniques to reduce substance use.
3
New cards
Stages of change in addiction recovery
Precontemplation, Contemplation, Preparation, Action, Maintenance.
4
New cards
Alcoholics Anonymous (AA)
An organization that some individuals may choose not to attend due to its religious affiliation.
5
New cards
I-RISA model
Impaired Response Inhibition and Salience Attribution, explaining attention bias and compulsive drug-seeking.
6
New cards
Supervised injection sites
Reduce harm by providing a safe environment for drug use and preventing overdoses.
7
New cards
Alcohol withdrawal symptoms
Severe tremors, hallucinations, seizures, and delirium tremens that may require hospitalization.
8
New cards
Dopamine
The primary neurotransmitter involved in addiction and reward systems.
9
New cards
Neonatal abstinence syndrome (NAS)
A withdrawal condition in newborns caused by prenatal exposure to opioids.
10
New cards
Relapse in addiction recovery
Often triggered by exposure to environmental cues that provoke cravings.
11
New cards
Evidence-based pharmacological treatments for SUDs
Methadone, Buprenorphine, and Naltrexone.
12
New cards
Key factors contributing to the opioid epidemic
Over-prescription, pharmaceutical marketing, and lack of regulatory oversight.
13
New cards
Motivational interviewing vs traditional directive therapy
Motivational interviewing is collaborative, avoids confrontation, and focuses on eliciting change talk.
14
New cards
Harm reduction strategies
Aim to minimize negative consequences of substance use rather than focusing solely on abstinence.
15
New cards
Thiamine deficiency in chronic alcohol use
Can lead to Wernicke-Korsakoff syndrome, causing memory impairment.
16
New cards
Cognitive impairments in long-term substance use
Reduced executive functioning, attention bias, and impaired decision-making.
17
New cards
Prefrontal cortex in addiction
Involved in impulse control and decision-making, which become impaired in addiction.
18
New cards
Physical dependence vs addiction
Dependence involves tolerance and withdrawal, while addiction includes compulsive drug-seeking behavior.
19
New cards
Social and psychological barriers to addiction treatment
Stigma, lack of access to care, and co-occurring mental health disorders.
20
New cards
Alcohol's effect on the gut microbiome
Disrupts healthy bacteria, leading to inflammation and cognitive changes.
21
New cards
Definitions of addiction
Characterized by loss of control and catastrophic consequences.
22
New cards
Addiction as a brain disorder
Involves functional changes to brain circuits related to reward, stress, and self-control.
23
New cards
Drug dependence vs drug abuse
Dependence is body adaptation to a drug; abuse is harmful use without addiction necessarily.
24
New cards
DSM-5 criteria for diagnosing SUD
A set of 11 criteria, with severity classified as mild (2-3 symptoms), moderate (4-5 symptoms), or severe (6+ symptoms).
25
New cards
Tolerance in substance use
Need for increasing amounts of a substance to achieve the same effect.
26
New cards
Withdrawal
Physical and psychological symptoms occurring when stopping or reducing drug use.
27
New cards
Prefrontal cortex's role
Regulates impulse control and decision-making, impaired in addiction.
28
New cards
Dopamine system in addiction
Reinforces drug-taking behavior by linking substance use to pleasure and reward.
29
New cards
Diathesis-Stress Model in addiction
Explains addiction as an interaction between genetic vulnerability and environmental stressors.
30
New cards
Risk of opioid withdrawal
Dehydration, which can be fatal if untreated.
31
New cards
Early childhood trauma and addiction risk
Adverse Childhood Experiences (ACEs) increase vulnerability to substance use disorders.
32
New cards
Opioids vs opiates
Opiates are naturally derived from the opium poppy, while opioids include synthetic substances.
33
New cards
Public health emergency declaration for opioid epidemic (2017)
Due to the significant increase in opioid-related overdoses and deaths.
34
New cards
Medication-Assisted Treatment (MAT)
Use of FDA-approved medications (e.g., methadone, buprenorphine) along with counseling for opioid use disorder.
35
New cards
Methadone's role in opioid addiction
Reduces cravings and withdrawal symptoms without producing a strong high.
36
New cards
Controversy surrounding supervised injection sites
Critics argue they encourage drug use, while proponents focus on harm reduction and overdose prevention.
37
New cards
Neonatal Abstinence Syndrome (NAS) significance
Condition in newborns withdrawing due to prenatal opioid exposure.
38
New cards
Long-term effects of fetal opioid exposure
Increased risk of cognitive deficits, behavioral issues, and developmental delays.
39
New cards
Wernicke-Korsakoff Syndrome
Severe neurological disorder from chronic alcohol use and thiamine deficiency leading to cognitive impairment.
40
New cards
Genetics in addiction
Studies show a high heritability rate (60-80%) for substance use disorders.
41
New cards
Dangers of alcohol mixed with caffeine
Caffeine masks alcohol's sedative effects, increasing overdose risk.
42
New cards
Purpose of harm reduction strategies
Minimize negative consequences of drug use instead of solely focusing on abstinence.
43
New cards
Goal of naltrexone in addiction treatment
Blocks pleasurable effects of substances, reducing cravings and relapse risk.
44
New cards
Social factors in SUDs
Peer pressure, trauma, socioeconomic factors, and family environment influence addiction risk.
45
New cards
Fentanyl vs other opioids
Fentanyl is 100 times stronger than morphine, with a high overdose risk.
46
New cards
Gut-liver-brain axis significance
Highlights how gut microbiota influence cognition, mood, and addictive behaviors.
47
New cards
Types of behavioral addictions
Gambling, binge eating, pornography, internet gaming, and compulsive shopping.
48
New cards
Connection between prenatal stress and addiction risk
High maternal stress predisposes children to substance use disorders later in life.
49
New cards
Incarcerated individuals' overdose risk post-release
They often lose tolerance while in prison and may overdose upon relapse.
50
New cards
1995 'Pain as the 5th Vital Sign' significance
Contributed to opioid overprescription by prioritizing patient-reported pain levels.
51
New cards
Alcohol Use Disorder (AUD) vs binge drinking
AUD is chronic, characterized by compulsive drinking and life impairment.
52
New cards
Cognitive impairments in long-term alcohol use
Includes memory loss, impaired decision-making, and decreased executive function.
53
New cards
Stigma's impact on addiction treatment
Discourages help-seeking behavior and reduces funding for harm reduction.
54
New cards
Naloxone's role in overdose prevention
Rapidly reverses opioid overdose effects by restoring normal breathing.
55
New cards
Primary withdrawal symptoms of alcohol
Shaking, sweating, nausea, seizures, and potentially delirium tremens.
56
New cards
2023 policy change for opioid addiction treatment
Elimination of the X-waiver requirement for prescribing buprenorphine.
57
New cards
Correlation of SUDs with mental health conditions
High rates of comorbidity with depression, anxiety, often fueling substance abuse.
58
New cards
Importance of early intervention in SUDs
Addressing risk factors early reduces likelihood of long-term addiction.